Sleep quality and immune mediators in asthmatic children

Ming-Fuu Wang1

  • 1Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Tungs' Taichung Metroharbor Hospital, Taichung, Taiwan. wmflily@yahoo.com.tw

Insights

Good sleep in asthmatic children is linked to lower IL-10 and higher prolactin levels. These findings suggest potential therapeutic targets for improving sleep quality in asthma patients.

Area of Science:

  • Pediatric Allergy and Immunology
  • Sleep Medicine
  • Immunology

Background:

  • Asthmatic children frequently report poor sleep quality.
  • Emerging research highlights the connection between sleep patterns and circulating cytokines.
  • This study investigates the link between serum cytokine levels and sleep quality in pediatric asthma patients.

Purpose of the Study:

  • To assess the relationship between serum cytokine levels and sleep quality in children with asthma.
  • To explore potential immune system markers associated with sleep disturbances in pediatric asthma.

Main Methods:

  • Ninety asthmatic children (aged 6-12) were enrolled after screening.
  • Participants completed the Childhood Asthma Control Test (ACT) and sleep quality questionnaires.
  • Serum levels of interleukin (IL)-4, IL-6, IL-10, IL-12, total immunoglobulin (Ig) E, and prolactin were measured.

Main Results:

  • Good sleepers in the well-controlled asthma group showed lower mean IL-10 levels and a higher IL-12/IL-10 ratio compared to poor sleepers.
  • Serum prolactin levels were significantly higher in good sleepers within the well-controlled group.
  • No significant differences in IL-6, IL-12, or total IgE levels were found between good and poor sleepers.

Conclusions:

  • Good sleep in asthmatic children is associated with a lower IL-10 level, higher prolactin concentration, and an elevated IL-12/IL-10 ratio.
  • Prolactin may play a role in the immune shifts observed in relation to sleep quality.
  • Further research into cytokine function could reveal novel therapeutic strategies for asthma-related sleep issues.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...